Literature DB >> 20058697

[A case of rapidly growing inflammatory myofibroblastic tumor in the lung].

Saiko Suetsugu1, Hidetaka Yamamoto, Miiru Izumi, Koichi Takayama, Hiromasa Inoue, Yoichi Nakanishi.   

Abstract

We report a case of a 28-year-old man with a dry cough and chest pain. Chest X-ray film showed a huge mass in the right lung field. Computed tomography (CT) and magnetic resonance imaging (MRI) showed a huge mass which occupied most of the right thoracic cavity and invaded the superior vena cava, heart atrium and right pulmonary vein. Positron emission tomography (PET) showed metastasis of bone, right adrenal grand and lymph nodes. A tumor specimen was biopsied percutaneously, and the diagnosis was pathologically confirmed as an inflammatory myofibroblastic tumor. Immunohistochemical staining also showed an overexpression of ALK in the tumor. He was treated with a non-steroid anti-inflammation drug and steroid, but they were ineffective. He underwent chemotherapy with bleomicin, etoposide and cisplatin. After two cycles of chemotherapy, the tumor slightly reduced in size, but was eventually refractory to the regimen finally. He also underwent with paclitaxel and carboplatin. At present, if operative extirpation is not possible, there is no way to treat an inflammatory myofibroblastic tumor. In the future, new therapy incorporating ALK inhibitors would be expected to treat those cases of IMT in which local recurrences and distant metastases occur.

Entities:  

Mesh:

Year:  2009        PMID: 20058697

Source DB:  PubMed          Journal:  Nihon Kokyuki Gakkai Zasshi        ISSN: 1343-3490


  1 in total

1.  A case of recurrent pulmonary inflammatory myofibroblastic tumor with aggressive metastasis after complete resection.

Authors:  Chae Ho Moon; Jong Ho Yoon; Geon Wook Kang; Seong Hyeon Lee; Jeong Su Baek; Seo Yun Kim; Hye-Ryoun Kim; Cheol Hyeon Kim
Journal:  Tuberc Respir Dis (Seoul)       Date:  2013-10-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.